๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

10 recruiting trials

for Essential Thrombocythemia (ET)

Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF) NCT06327100Phase 1, Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Ruxolitinib, Tasquinimod Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients NCT04655092Phase 36 sites๐Ÿ“ Toon-shi๐Ÿ“ Tsu๐Ÿ“ Suita-shi PharmaEssentia Japan K.K. ยท Tests: P1101 (Ropeginterferon alfa-2b) Peginterferon ฮฑ-2b Injection for Hydroxyurea Resistant or Intolerant ET NCT06552429Phase 28 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Fujian Xiamen Amoytop Biotech Co., Ltd. ยท Tests: Peginterferon ฮฑ-2b injection, Peginterferon ฮฑ-2b injection Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm NCT07590986n/a1 site๐Ÿ“ Brussels Universitรฉ Catholique de Louvain Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120) NCT05835466Phase 29 sites๐Ÿ“ Tampa๐Ÿ“ Atlanta๐Ÿ“ Buffalo Icahn School of Medicine at Mount Sinai ยท Tests: reparixin MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial NCT06541249Phase 21 site๐Ÿ“ New York Icahn School of Medicine at Mount Sinai ยท Tests: Methotrexate (MTX) MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) NCT07362225n/a2 sites๐Ÿ“ Chicago๐Ÿ“ New York MPN Research Foundation Efficacy and Safety of Peginterferon in ET and PV. NCT06734637NA1 site๐Ÿ“ Wuhan Zhenya Hong ยท Tests: Peginterferon ฮฑ-2b injection Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis NCT07612280Phase 1, Phase 27 sites๐Ÿ“ Sydney๐Ÿ“ Sydney๐Ÿ“ Adelaide Jubilant Therapeutics Inc. ยท Tests: JBI-802 National Longitudinal Cohort of Hematological Diseases NCT04645199n/a1 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy